<?xml version="1.0" encoding="UTF-8"?>
<p>Immunotherapy using anti-CHIKV monoclonal antibodies represents a different approach for therapeutic and post-exposure interventions, and studies conducted on mice models evidenced good protection, even when administered at later time points after infection [
 <xref rid="B208-viruses-11-00175" ref-type="bibr">208</xref>,
 <xref rid="B215-viruses-11-00175" ref-type="bibr">215</xref>].
</p>
